Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (åpner nytt vindu)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Kilde‎: Anesth Analg 2006;102(3):731-7.

Arkiv‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (åpner nytt vindu)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (åpner nytt vindu)

Basta MN, Stricker PA, Taylor JA.

Kilde‎: Pediatr Surg Int 2012;28(11):1059-69.

Arkiv‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (åpner nytt vindu)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (åpner nytt vindu)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Kilde‎: Br J Anaesth 2012;108(5):830-7.

Arkiv‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (åpner nytt vindu)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (åpner nytt vindu)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Kilde‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Arkiv‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (åpner nytt vindu)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (åpner nytt vindu)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Kilde‎: Ann Thorac Surg 2000;70(4):1308-12.

Arkiv‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (åpner nytt vindu)

The Bayer 022 compassionate-use pediatric study. (åpner nytt vindu)

Coniff RF.

Kilde‎: Ann Thorac Surg 1998;65(6 Suppl):S31-3.

Arkiv‎: PubMed 9647135

https://www.ncbi.nlm.nih.gov/pubmed/9647135 (åpner nytt vindu)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (åpner nytt vindu)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Kilde‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Arkiv‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (åpner nytt vindu)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (åpner nytt vindu)

Guay J, de Moerloose P, Lasne D.

Kilde‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Arkiv‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (åpner nytt vindu)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (åpner nytt vindu)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Kilde‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Arkiv‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (åpner nytt vindu)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (åpner nytt vindu)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Kilde‎: PLoS One 2015;10(5):e0126514.

Arkiv‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (åpner nytt vindu)

Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (åpner nytt vindu)

Lu J, Meng H, Meng Z, Sun Y, Pribis JP, Zhu C, Li Q.

Kilde‎: Int J Clin Exp Pathol 2015;8(7):7978-87.

Arkiv‎: PubMed 26339364

https://www.ncbi.nlm.nih.gov/pubmed/26339364 (åpner nytt vindu)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (åpner nytt vindu)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Kilde‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Arkiv‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (åpner nytt vindu)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (åpner nytt vindu)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Kilde‎: Br J Anaesth 2013;110(4):615-21.

Arkiv‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (åpner nytt vindu)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (åpner nytt vindu)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Kilde‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Arkiv‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (åpner nytt vindu)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (åpner nytt vindu)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Kilde‎: Ann Card Anaesth 2015;18(1):23-6.

Arkiv‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (åpner nytt vindu)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (åpner nytt vindu)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Kilde‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Arkiv‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (åpner nytt vindu)

The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (åpner nytt vindu)

Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA.

Kilde‎: Anesth Analg 1997;84(5):990-6.

Arkiv‎: PubMed 9141920

https://www.ncbi.nlm.nih.gov/pubmed/9141920 (åpner nytt vindu)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (åpner nytt vindu)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Kilde‎: Eur J Anaesthesiol 2015;32(12):844-50.

Arkiv‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (åpner nytt vindu)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (åpner nytt vindu)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Kilde‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Arkiv‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (åpner nytt vindu)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (åpner nytt vindu)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Kilde‎: Ann Card Anaesth 2010;13(2):110-5.

Arkiv‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (åpner nytt vindu)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (åpner nytt vindu)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Kilde‎: Anesthesiology 2015;122(4):746-58.

Arkiv‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (åpner nytt vindu)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (åpner nytt vindu)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Kilde‎: Ann Thorac Surg 2011;92(3):958-63.

Arkiv‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (åpner nytt vindu)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (åpner nytt vindu)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Kilde‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Arkiv‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (åpner nytt vindu)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (åpner nytt vindu)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Kilde‎: Ann Thorac Surg 2007;84(1):161-8.

Arkiv‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (åpner nytt vindu)

Pediatric off-label use of recombinant factor VIIa. (åpner nytt vindu)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Kilde‎: Pediatrics 2009;123(3):1066-72.

Arkiv‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (åpner nytt vindu)

Factor VII for excessive bleeding following congenital heart disease surgery. (åpner nytt vindu)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Kilde‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Arkiv‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (åpner nytt vindu)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (åpner nytt vindu)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Kilde‎: Paediatr Anaesth 2009;19(4):364-70.

Arkiv‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (åpner nytt vindu)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (åpner nytt vindu)

Guzzetta NA, Russell IA, Williams GD.

Kilde‎: Anesth Analg 2012;115(2):364-78.

Arkiv‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (åpner nytt vindu)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (åpner nytt vindu)

Okonta KE, Edwin F, Falase B.

Kilde‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Arkiv‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (åpner nytt vindu)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (åpner nytt vindu)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Kilde‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Arkiv‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (åpner nytt vindu)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (åpner nytt vindu)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Kilde‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Arkiv‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (åpner nytt vindu)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (åpner nytt vindu)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Kilde‎: J Clin Anesth 2014;26(3):204-11.

Arkiv‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (åpner nytt vindu)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (åpner nytt vindu)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Kilde‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Arkiv‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (åpner nytt vindu)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (åpner nytt vindu)

Tobias JD, Berkenbosch JW, Russo P.

Kilde‎: Pediatr Crit Care Med 2003;4(1):49-51.

Arkiv‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (åpner nytt vindu)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (åpner nytt vindu)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Kilde‎: J Intensive Care Med 2004;19(5):270-3.

Arkiv‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (åpner nytt vindu)

Recombinant activated factor VII in cardiac surgery: a systematic review. (åpner nytt vindu)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Kilde‎: Ann Thorac Surg 2007;83(2):707-14.

Arkiv‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (åpner nytt vindu)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (åpner nytt vindu)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Kilde‎: Pediatr Crit Care Med 2009;10(5):572-82.

Arkiv‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (åpner nytt vindu)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (åpner nytt vindu)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Kilde‎: Pediatr Cardiol 2013;34(1):119-24.

Arkiv‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (åpner nytt vindu)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (åpner nytt vindu)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Kilde‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Arkiv‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (åpner nytt vindu)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (åpner nytt vindu)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Kilde‎: Artif Organs 2010;34(11):955-60.

Arkiv‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (åpner nytt vindu)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (åpner nytt vindu)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Kilde‎: Eur J Anaesthesiol 2014;31(6):317-26.

Arkiv‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (åpner nytt vindu)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (åpner nytt vindu)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Kilde‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Arkiv‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (åpner nytt vindu)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (åpner nytt vindu)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Kilde‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Arkiv‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (åpner nytt vindu)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (åpner nytt vindu)

Noga T, Bruce AA, Blain H, Nahirniak S.

Kilde‎: Vox Sang 2016;110(3):253-7.

Arkiv‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (åpner nytt vindu)

Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (åpner nytt vindu)

Guay J, de Moerloose P, Lasne D.

Kilde‎: Can J Anaesth 2006;53(6 Suppl):S59-67.

Arkiv‎: PubMed 16766791

https://www.ncbi.nlm.nih.gov/pubmed/16766791 (åpner nytt vindu)

Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (åpner nytt vindu)

Macksey LF, White B.

Kilde‎: AANA J 2007;75(4):261-4.

Arkiv‎: PubMed 17711156

https://www.ncbi.nlm.nih.gov/pubmed/17711156 (åpner nytt vindu)

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (åpner nytt vindu)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Kilde‎: Ann Surg 2010;251(2):217-28.

Arkiv‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (åpner nytt vindu)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (åpner nytt vindu)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Kilde‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Arkiv‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (åpner nytt vindu)

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (åpner nytt vindu)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Kilde‎: Ann Card Anaesth 2012;15(1):26-31.

Arkiv‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (åpner nytt vindu)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (åpner nytt vindu)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Kilde‎: Artif Organs 2010;34(11):955-60.

Arkiv‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (åpner nytt vindu)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (åpner nytt vindu)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Kilde‎: Br J Anaesth 2015;114(1):91-102.

Arkiv‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (åpner nytt vindu)